(Q37359290)

19 August 2017

1 reference

title

Optimal timing of chemotherapy in androgen independent prostate cancer (English)

1 reference

19 August 2017

1 reference

1 reference

2

Tomasz M Beer

1 reference

19 August 2017

Ian D Schnadig

1

1 reference

19 August 2017

publication date

1 January 2009

1 reference

19 August 2017

1 reference

19 August 2017

volume

27

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

97-100

1 reference

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.004

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.004

American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.004

Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.004

Secondary hormonal manipulations in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.004

Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.004

Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.004

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.004

Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.04.004

10.1016/J.UROLONC.2008.04.004

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference